← back to search

Shizhi Wang

Nanchang University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Medicine, Biology, Oncology, Immune system, microRNA, and Internal medicine.
h-index
citations
356
works
18
NIH funding
primary concept
email

Recent publications

M6A plays a potential role in carotid atherosclerosis by modulating immune cell modification and regulating aging-related genes
Scientific Reports 2024cited by 14position: lastdoi
Transcriptional and post-transcriptional regulation of CARMN and its anti-tumor function in cervical cancer through autophagic flux blockade and MAPK cascade inhibition
Journal of Experimental & Clinical Cancer Research 2024cited by 4position: lastdoi
LINC00426, a novel m6A-regulated long non-coding RNA, induces EMT in cervical cancer by binding to ZEB1
Cellular Signalling 2023cited by 12position: lastdoi
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
Frontiers in Genetics 2022cited by 13position: lastdoi
Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer
Cancer Cell International 2021cited by 26position: lastdoi
Positive association between body fat percentage and hyperuricemia in patients with hypertension: The China H-type hypertension registry study
Nutrition Metabolism and Cardiovascular Diseases 2021cited by 25position: middledoi
Metabolomics-based molecular signatures reveal the toxic effect of co-exposure to nitrosamines in drinking water
Environmental Research 2021cited by 19position: middledoi
Based on bioinformatics analysis lncrna SNHG5 modulates the function of vascular smooth muscle cells through mir‐205‐5p/SMAD4 in abdominal aortic aneurysm
Immunity Inflammation and Disease 2021cited by 16position: middledoi
Circular RNA RBM33 contributes to extracellular matrix degradation <i>via</i> miR-4268/EPHB2 axis in abdominal aortic aneurysm
PeerJ 2021cited by 15position: firstdoi
Esophageal Cancer Associated Immune Genes as Biomarkers for Predicting Outcome in Upper Gastrointestinal Tumors
Frontiers in Genetics 2021cited by 13position: lastdoi
Fanconi Anemia Pathway Genes Advance Cervical Cancer via Immune Regulation and Cell Adhesion
Frontiers in Cell and Developmental Biology 2021cited by 8position: firstdoi
Identification of an immune signature to predict poor clinical outcome in cervical cancer
Epigenomics 2021cited by 4position: lastdoi
&lt;p&gt;Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Recurrence in Patients with Cervical Cancer&lt;/p&gt;
Cancer Management and Research 2020cited by 29position: lastdoi
Five immune‐gene‐signatures participate in the development and pathogenesis of Kawasaki disease
Immunity Inflammation and Disease 2020cited by 24position: middledoi
Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer
International Immunopharmacology 2020cited by 3position: lastdoi
Genetic variants in microRNAs are associated with cervical cancer risk
Mutagenesis 2019cited by 24position: firstdoi
HOTAIR rs7958904 polymorphism is associated with increased cervical cancer risk in a Chinese population
Scientific Reports 2017cited by 41position: lastdoi
Role of microRNA-4516 involved autophagy associated with exposure to fine particulate matter
Oncotarget 2016cited by 47position: middledoi
A functional polymorphism in <i>MIR</i><i>196</i><i>A</i><i>2</i> is associated with risk and prognosis of gastric cancer
Molecular Carcinogenesis 2013cited by 38position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Hua Jin · Fudan University10 papers (2017–2023)Wenjing Yan · China Pharmaceutical University8 papers (2020–2023)Dan Meng · Shanghai Medical College of Fudan University7 papers (2020–2024) · 6 papers (2017–2022)Qianqian Xia · Huazhong Agricultural University6 papers (2020–2022)Xing Zhang · Nanjing University of Chinese Medicine6 papers (2020–2022) · 5 papers (2021–2023)Siyuan Shen · Technical University of Munich4 papers (2021–2023)Weimin Zhou · Nanchang University4 papers (2020–2024)Haixia Zhu · Fudan University4 papers (2013–2020)Bo Ding · Nanjing Medical University4 papers (2019–2021)Wenpeng Zhao · Nanchang University3 papers (2021–2024)Dake Li · Fudan University3 papers (2020–2021) · 3 papers (2017–2021) · 2 papers (2023–2024)Yun Gu · Tianjin University of Traditional Chinese Medicine2 papers (2021–2023)Yuling Xu · Nanchang University2 papers (2017–2019)Yuepu Pu · Ministry of Education of the People's Republic of China2 papers (2016–2021) · 2 papers (2023–2024)Haohan Liu · Sun Yat-sen University2 papers (2023–2024)